21032 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof; Enzymes; Proenzymes; Derivatives thereof; Hydrolases (3) acting on peptide bonds (3.4) Serine endopeptidases (3.4.21)
FIBRINOLYTIC COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF PHLEBOTHROMBOTIC STATES
#302Blends of strains and enzymes
#303Peptide directed protein knockdown
#304Diagnostic marker for treatment of cerebral ischemia
#305Compositions and Methods for Treating Stroke
#306Nutritional compositions containing a prebiotic and lactoferrin and uses thereof
#307PATIENT REPORTED OUTCOME INSTRUMENT
#308Acid Stable Prolyl Endopeptidases for Degrading Gluten
#309Plasminogen activator mutants as anti-fibrinolytic agents
#310MINERAL SALT-SULFONIC ACID COMPOSITIONS AND METHODS OF USE
#311CHIMERIC NEUREGULINS AND METHOD OF MAKING AND USE THEREOF
#312METHODS AND KITS FOR REVERSIBLE ADHESION OF IMPLANTS TO AN EYE SCLERA
#313Use of proteases for gluten intolerance
#314Heat-inactivated complement factor B compositions and methods
#315LACTOFERRIN SUPPLEMENTATION AND DIARRHEA
#316AEROSOL DELIVERY SYSTEMS, COMPOSITIONS AND METHODS
#317Controlled release of biological entities
#318NANOTHERAPEUTICS FOR DRUG TARGETING
#319CARTILAGE REGENERATION-PROMOTING AGENT
#320Lipid nanoparticle compositions and methods of making and methods of using the same
#321Use of seaprose to remove bacterial biofilm
#322Gelatinase inhibitors and prodrugs
#323Formulations of recombinant furin
#324Sterically Stabilized Carrier For Aerosol Therapeutics, Compositions And Methods For Treating The Respiratory Tract Of A Mammal
#325Nanoparticles for controlled lysis of blood clots
#326Dry glassy composition comprising a bioactive material
#327Combination therapy for treatment of patients with neurological disorders and cerebral infarction
#328Pharmaceutical Composition Producing antioxidant, antimicrobal, antitoxic protein - human lactoferrin, production process and therapeutic method.
#329USE OF SERINE PROTEASE INHIBITORS IN THE TREATMENT OF SKIN DISEASES
#330METHODS AND COMPOSITIONS FOR ENHANCING CD4+ REGULATORY T CELLS
#331LACTOFERRIN DERIVED PEPTIDES FOR USE AS BROAD-SPECTRUM INHIBITORS OF INFLUENZA VIRUS INFECTION
#332NOVEL PATIENT SUBGROUPS FOR THROMBOLYSIS
#333REPROGRAMMING UROKINASE INTO AN ANTIBODY-RECRUITING ANTICANCER AGENT
#334Tau protease compositions and methods of use
#335Particulate hyaluronic acid and flavonoid formulations for cellular delivery of bioactive agents
#336Methods and compositions for treating cancer
#337Methods of treatment of cellulite
#338METHODS FOR IMPROVING GUT HEALTH
#339Treatments for
#340Modified MT-SP1 proteases that inhibit complement activation
#341Modified factor X polypeptides and uses thereof
#342Chimeric neuregulins and method of making and use thereof
#343Use of CGRP antagonist compounds for treatment of psoriasis
#344WOUND CLEANING CHEMICAL COMPOSITION AND METHOD FOR MANUFACTURING
#345Cell therapy for the treatment of neurodegeneration
#346Fibrinolytic/Proteolytic Treatment of Myofacial and Neuropathic Pain and Related Conditions
#347Proteases for Degrading Gluten
#348Aerogel compositions
#349WOUND DEBRIDEMENT COMPOSITIONS CONTAINING SEAPROSE AND METHODS OF WOUND TREATMENT USING SAME
#350Compositions and methods of use of phorbol esters for the treatment of stroke
#351MASP-2, a complement fixing enzyme, and uses for it
#352METHODS AND COMPOSITIONS USING NEUROPROTECTIVE STEROIDS AND THROMBOLYTIC AGENTS
#353Chimeric neuregulins and method of making and use thereof
#354Chimeric neuregulins and method of making and use thereof
#355Methods of treating a subject for a condition
#356protein in for use as a medicament
#357Modified factor X polypeptides and uses thereof
#358Compositions and methods for the treatment of hepatic diseases and disorders
#359DODECAFLUOROPENTANE EMULSION AS A STROKE AND ISCHEMIA THERAPY
#360KERATIN BIOMATERIALS FOR TREATMENT OF ISCHEMIA
#361PHARMACEUTICAL COMPOSITIONS OF TENECTEPLASE
#362Composition comprising a combination of at least one proteolytic enzyme and at least one lipolytic enzyme, for use in preventing triglyceride synthesis
#363Method of isolating cells from a tissue in a mammal
#364Lipid nanoparticle compositions for antisense oligonucleotides delivery
#365Method for inducing tissue growth, differentiation and/or regeneration by delivering a GDF-5 related precursor protein
#366Treatment and prophylaxis for obsessive compulsive disorder
#367Non-cytotoxic protein conjugates
#368ANTI-FOULING COMPOSITION COMPRISING AN AEROGEL
#369VACCINATION AGAINST PCSKK 9 FOR LOWERING CHOLESTEROL
#370ANTIFUNGAL COMPOSITION
#371Capsule which disintegrates specifically in the large intestine
#372Treatment of acute ischemic stroke or intracranial bleeding with tPa and carbamylated erythropoietin
#373ANTI-ANDROGENIC AGENT, SEBUM SECRETION BLOCKER, HAIR GROWTH STIMULANT, AND FOOD OR BEVERAGE
#374Integrated infusion container
#375COMPOSITION COMPRISING A COMBINATION OF AT LEAST ONE PROTEOLYTIC ENZYME AND AT LEAST ONE LIPOLYTIC ENZYME, FOR USE IN PREVENTING TRIGLYCERIDE SYNTHESIS
#376WOUND CLEANING CHEMICAL COMPOSITION AND METHOD FOR MANUFACTURING
#377species gluten-degrading enzymes and uses thereof
#378PROTEASE ENZYMES FOR INCREASED PROTEIN DIGESTION RATE AND ABSORPTION AND METHODS OF USING THE SAME
#379NOVEL DIAGNOSTIC AND THERAPEUTIC TARGET IN INFLAMMATORY AND/OR CARDIOVASCULAR DISEASES
#380FURIN AND BIOLOGICALLY ACTIVE DERIVATIVES THEREOF FOR USE IN THE PREVENTION OR TREATMENT OF AN INFLAMMATORY DISEASE
#381Inhibition of microbial growth by aconitase inhibition
#382LACTOFERRIN SEQENCES, COMPOSITIONS AND METHODS FOR CORNEAL WOUND TREATMENT
#383PROTEASE FOR TREATING NAIL ABNORMALITIES
#384Gelatinase inhibitors and prodrugs
#385Use of proteases for gluten intolerance
#386Compositions and methods for treating inflammatory bowel disease and airway inflammation
#387Proteolytic enzyme formulations
#388Formulations of recombinant furin
#389Modulation of synaptic maintenance
#390Injection of fibrin sealant using reconstituted components in spinal applications
#391Dry glassy composition comprising a bioactive material
#392Devices for controlling magnetic nanoparticles to treat fluid obstructions
#393Methods of controlling magnetic nanoparticles to improve vascular flow
#394SYNERGIC ACTION OF A PROLYL PROTEASE AND TRIPEPTIDYL PROTEASES
#395MINERAL SALT-SULFONIC ACID COMPOSITIONS AND METHODS OF USE
#396Modified proteases that inhibit complement activation
#397Magnetic-based methods for treating vessel obstructions
#398Fusion proteins
#399Magnetic-based systems for treating occluded vessels
#400Methods for improving gut health
#401Glycopegylation methods and proteins/peptides produced by the methods
#402MASP 2, a complement-fixing enzyme, and uses for it
#403Enzymes For Pharmaceutical Use
#404Treatment of pain
#405Enzyme treatment of foodstuffs for celiac sprue
#406Particulate hyaluronic acid/flavonoid suspensions for cellular delivery of bioactive agents
#407Treatment of diseases related to hyperactivity of the complement system
#408Apparatus and method for delivery of biological sealant
#409Diagnostic method for celiac sprue
#410CHIMERIC TRUNCATED AND MUTANT VARIANT OF TISSUE PLASMINOGEN ACTIVATOR (T-PA) RESISTANT TO PLASMINOGEN ACTIVATOR INHIBITOR-1
#411Non-cytotoxic protein conjugates
#412COMPOSITIONS FOR REDUCING THE DELETERIOUS EFFECTS OF STRESS AND AGING
#413Treatment of ocular diseases
#414Methods for the treatment and the prognostic assessment of malignant pleural mesothelioma
#415Enzyme treatment of foodstuffs for celiac sprue
#416Combination therapy for treatment of patients with neurological disorders and cerebral infarction
#417Keratin biomaterials for treatment of ischemia
#418SCREENING METHOD FOR POLYMORPHIC MARKERS IN HTRA1 GENE IN NEURODEGENERATIVE DISORDERS
#419Polymerized Hemoglobin Media And Its Use In Isolation And Transplantation of Islet Cells
#420USE OF PROTEASES FOR GLUTEN INTOLERANCE
#421Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions
#422Methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions
#423Methods comprising serratia peptidase for inhibition of osteomyelitis
#424Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions
#425Compositions and methods comprising serratia peptidase for inhibition of bacterial vaginosis, bacterial vaginitis or fungal vaginitis
#426COMPOSITIONS AND METHODS COMPRISING SERRATIA PEPTIDASE FOR INHIBITION AND TREATMENT OF BIOFILMS RELATED TO CERTAIN CONDITIONS
#427Corin for Treating Obesity and Diabetes
#428Enzymes for pharmaceutical use
#429USE OF CGRP ANTAGONIST COMPOUNDS FOR TREATMENT OF PSORIASIS
#430Use of proline specific endoproteases to hydrolyse peptides and proteins
#431Polymerized Hemoglobin Media and Its Use in Isolation and Transplantation of Islet Cells
#432USE OF SERINE PROTEASE INHIBITORS IN THE TREATMENT OF SKIN DISEASES
#433Methods of comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions
#434Neutralizing proprotein convertase subtilisin kexin type 9 (PCSK9) variants and uses thereof
#435FUSION PROTEINS
#436DispersinB™, 5-fluorouracil, deoxyribonuclease I and proteinase K-based antibiofilm compositions and uses thereof
#437Proteinases destroy cancer tumor's solid structure and kill cancer cells locally
#438Treatment/Cure of Autoimmune Disease
#439AEROGEL COMPOSITIONS
#440HAEMOSTASIS-MODULATING COMPOSITIONS AND USES THEREFOR
#441METHOD OF TREATMENT AND AGENTS USEFUL FOR SAME
#442COMPOSITIONS AND METHODS COMPRISING BASIC AMINO ACID PEPTIDES AND PROTEASES
#443Diffusion enhancing compounds and their use alone or with thrombolytics
#444Combination Enzyme Therapy for Gastric Digestion of Dietary Gluten in Celiac Sprue Patients
#445Diagnostic method for celiac sprue
#446ALTERED N-CADHERIN PROCESSING IN TUMOR CELLS BY FURIN AND PROPROTEIN CONVERTASE 5A (PC5A)
#447DHA and PEDF, a Therapeutic Composition for Nerve and Retinal Pigment Epithelial Cells
#448Protective Complement Proteins and Age-Related Macular Degeneration
#449NOVEL PATIENT SUBGROUPS FOR THROMBOLYSIS
#450ANTI-FOULING COMPOSITION COMPRISING AN AEROGEL
#451Antidotes for factor Xa inhibitors and methods of using the same
#452ENZYME DISRUPTION OF BACTERIAL BIOFILMS
#453MATERIALS AND METHODS FOR DELIVERING COMPOSITIONS TO SELECTED TISSUES
#454METHODS AND USES RELATED TO RHBDL4
#455Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism
#456Proteolytic enzyme formulations
#457Human growth and differentiation factor GDF-5
#458Antidotes for factor Xa inhibitors and methods of using the same in combination with blood coagulating agents
#459Effect of Bri Proteins on Ass Production
#460Combination enzyme therapy for digestion of dietary gluten
#461COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION COMPRISING AN ENZYME WHICH IS INSOLUBLE IN AN AQUEOUS MEDIUM AS WELL AS ITS USES
#462Glycopegylation methods and proteins/peptides produced by the methods
#463TREATMENT OF PAIN
#464Methods of treatment of collagen-mediated diseases and conditions
#465Therapeutic Peptide Compositions And Methods Of Making And Using Same
#466ENZYME TREATMENT OF FOODSTUFFS FOR CELIAC SPRUE
#467MASP-2, A COMPLEMENT FIXING ENZYME, AND USES FOR IT
#468Controlled release of biological entities
#469BIOLOGICAL ENTITIES AND THE USE THEREOF
#470BIOLOGICAL ENTITIES AND THE USE THEREOF
#471ADAPTABLE MESSENGER RIBONUCLEIC ACID MEDICAL TREATMENT DEVICE TO MANAGE DIABETES MELLITUS
#472Methods for growing tissue with Lopap-based pharmaceutical compositions
#473PEPTIDES FOR DIAGNOSTIC AND THERAPEUTIC METHODS FOR CELIAC SPRUE
#474Therapeutic methods that target the NCchannel
#475Collagenolytic active enzyme containing compositions, and their use in the dental field
#476NON-PANCREATIC PROTEASES FOR CONTROLLING PLASMA CHOLECYSTOKININ (CCK) CONCENTRATION AND FOR TREATING PAIN
#477Compositions for Topical Enzymatic Debridement
#478Compositions and methods for enhanced gastrointestinal stability of oligopeptides and polypeptides
#479Peptides for Diagnostic and Therapeutic Methods for Celiac Sprue
#480Treatment for eye disorder
#481Protective complement proteins and age-related macular degenration
#482Immunotherapeutic methods targeted toward stratum corneum chymotryptic enzyme
#483Integrated infusion container
#484Compositions containing lysozyme and C-1/C-4 polysaccharides and use thereof in oral care, cosmetology and dermatology, contraception, urology and gynecology
#485Methods for diagnosing celiac sprue and reagents useful therein
#486Enzyme treatment of foodstuffs for celiac sprue
#487Enzyme treatment of foodstuffs for Celiac Sprue
#488Enzyme containing composition, process of producing said composition and its use
#489Therapeutic enzyme formulations and uses thereof in celiac sprue and/or dermatitis herpetoformis
#490Use of glycodendrimer reagents for inhibiting adhesion by microorganisms
#491Protective complement proteins and age-related macular degeneration
#492Enzyme treatment of foodstuffs for celiac sprue
#493BIOLOGICAL PESTICIDE
#494Enzyme treatment of foodstuffs for celiac sprue
#495Apparatus and method for delivery of biologic sealant
#496Enzymatic debridement therapy for abnormal cell proliferation
#497Method for inhibiting apoptosis through the p75 neurotrophin receptor
#498Proteinases destroy cancer tumor's solid structure and kill cancer cells locally
#499Compositions for Topical Enzymatic Debridement
#500Sting kit apparatus and method of use
#501Compositions and methods for the cure of HIV / AIDS
#502Inhibition of nephrotoxicity induced by Trasylol® and like agents
#503Methods for treating local tracheal, bronchial or alveolar bleeding or hemoptysis
#504Drug delivery means
#505Preparation for Topical Application and Methods of Delivering an Active Agent to a Substrate
#506Protease compositions for the treatment of damaged tissue
#507Polymerized Hemoglobin Media and its Use in Isolation and Transplantation of Islet Cells
#508Method for providing an active agent topically to the skin
#509Drug therapy for Celiac Sprue
#510PREPARATIONS FOR TOPICAL SKIN USE AND TREATMENT
#511Preparation comprising batroxobin for inhibiting local invasion of malignant tumors
#512Modified proteases that inhibit complement activation
#513Enzyme inhibitors of PAI-1
#514Methods for preventing and treating local tracheal, bronchial or alveolar bleeding or hemoptysis
#515MASP-2, a complement-fixing enzyme, and uses for it
#516Use of proline specific endoproteases to hydrolyse peptides and proteins
#517Glycopegylation methods and proteins/peptides produced by the methods
#518Ointment wound spray
#519Diagnostic method for Celiac Sprue
#520Method and composition for preventing or reducing edema, deep vein thrombosis and/or pulmonary embolism
#521Method for reducing obstructive hydrocephalus
#522Peptides for diagnostic and therapeutic methods for celiac sprue
#523Composition for mitigating a pernicious thrombotic event
#524Compositions for preventing and treating digestive organs diseases
#525Additive for an animal feed
#526Enzymatic inactivation of transmissible spongiform encephalopathy agents and dectection there of
#527Enzyme containing composition, process of producing said composition and its use
#528Use of granzyme b as an hsp70/hsp70 peptide dependent inducer of apoptosis in tumor cells
#529Compositions for inhibiting thrombin-induced coagulation and methods of use
#530Activators and inhibitors of protease activated receptor2 (PAR2) and methods of use
#531Injection of fibrin sealant using reconstituted components in spinal applications
#532Methods of treating a subject for a condition
#533Composition for promoting lacrimal secretion
#534Methods for treating conditions associated with lectin-dependent complement activation
#535Glutenase enzyme assays
#536Compositions for topical enzymatic debridement
#537Methods for inhibiting angiogenesis and or lymphangiogenesis
#538Collagenolytic active enzyme containing compositions, and their use in the dental field
#539Drug therapy for celiac sprue
#540Enzyme treatment of foodstuffs for Celiac Sprue
#541Method of treatment for stroke employing administration of defibrinogenating agents to achieve a specific defibrinogenation pattern
#542Therapeutic composition containing a plurality of immobilized proteases
#543Biological entities and the pharmaceutical and diagnostic use thereof
#544Treating abdominal pain due to pancreatitis with seaprose
#545MASP-2, a complement-fixing enzyme, and uses for it
#546TGF-beta activation and use
#547Engineered enzymes and uses thereof
#548Composition and method for treatment of wounds
#549Treatment for dry macular degeneration
#550Ointment wound spray
#551Composition for mitigating a pernicious thrombotic event
#552Biological entities and the pharmaceutical or diagnostic use thereof
#553Compositions and methods for prevention and treatment of coronavirus and related disorders
#554Compositions and methods for treating stroke